A significant influence on a stock price, at least over the short term, is how a company's quarterly earnings are perceived.

UnitedHealth, America's largest health insurance provider, is trading at its lowest valuation in over a decade. Check out why I'm rating UNH stock a strong buy.

UnitedHealth Group (NYSE:UNH) has dipped below $300 today, though it is still up from its trough after a massive 51% crash ...

UnitedHealth Group (UNH ... those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13% to 16%." The company posted adjusted EPS ...

Simultaneously, AM Best has revised the outlook to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) for the health and ...

Our EPS expectation is significantly below management's long-term goal of 13%-16 ... see signs of weak execution at UnitedHealth, including a suspended 2025 outlook due to a mismatch in rates ...

UnitedHealth added 800,000 Medicare Advantage members in Q1 FY 2025. Click here to find out why UNH stock is a Buy.

return to our long-term growth objective of 13 to 16 percent," Hemsley continued. UnitedHealth Group on Tuesday also announced it has suspended its 2025 outlook as "care activity continued to ...

“UnitedHealth Group…did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead and return to our long-term earnings ...